Symbol
| IMPDH2
| contributors: mct - updated : 20-04-2015
|
HGNC name
| IMP (inosine monophosphate) dehydrogenase 2
|
HGNC id
| 6053
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in osteosarcoma patients with poor response to chemotherapy | |
Susceptibility
|
to resistance to immunosuppressive drug, mycophenolic acid (MPA) |
Variant & Polymorphism
SNP
| increasing the risk of resistance to immunosuppressive drug, mycophenolic acid (MPA)( |
|
|
Candidate gene
Marker
| may be a protein biomarker in colorectal cancer ( | |
| Therapy target
|
System | Type | Disorder | Pubmed |
cancer | bone | | |
targeting of IMPDH2 by RNAi or more effective pharmacological inhibitors in combination with chemotherapy might be a promising means of overcoming chemoresistance in osteosarcomas with high IMPDH2 expression | cancer | digestive | colon | |
novel therapeutic target in colorectal cancer |
| | |